These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A Protective Role for Interleukin-1 Signaling during Mouse Adenovirus Type 1-Induced Encephalitis. Castro-Jorge LA; Pretto CD; Smith AB; Foreman O; Carnahan KE; Spindler KR J Virol; 2017 Feb; 91(4):. PubMed ID: 27903802 [TBL] [Abstract][Full Text] [Related]
7. Contribution of a single host genetic locus to mouse adenovirus type 1 infection and encephalitis. Hsu TH; Althaus IW; Foreman O; Spindler KR mBio; 2012; 3(3):. PubMed ID: 22647790 [TBL] [Abstract][Full Text] [Related]
8. Effects of tumor necrosis factor on viral replication and pulmonary inflammation during acute mouse adenovirus type 1 respiratory infection. Pant K; Chandrasekaran A; Chang CJ; Vageesh A; Popkov AJ; Weinberg JB Virology; 2020 Aug; 547():12-19. PubMed ID: 32560900 [TBL] [Abstract][Full Text] [Related]
10. Mouse adenovirus type 1 infection of macrophages. Ashley SL; Welton AR; Harwood KM; Van Rooijen N; Spindler KR Virology; 2009 Aug; 390(2):307-14. PubMed ID: 19540545 [TBL] [Abstract][Full Text] [Related]
11. Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase. Moore ML; McKissic EL; Brown CC; Wilkinson JE; Spindler KR J Virol; 2004 Jun; 78(11):5584-90. PubMed ID: 15140955 [TBL] [Abstract][Full Text] [Related]
12. Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Naesens L; Lenaerts L; Andrei G; Snoeck R; Van Beers D; Holy A; Balzarini J; De Clercq E Antimicrob Agents Chemother; 2005 Mar; 49(3):1010-6. PubMed ID: 15728896 [TBL] [Abstract][Full Text] [Related]
13. Human adenovirus type 37 and the BALB/c mouse: progress toward a restricted adenovirus keratitis model (an American Ophthalmological Society thesis). Chodosh J Trans Am Ophthalmol Soc; 2006; 104():346-65. PubMed ID: 17471351 [TBL] [Abstract][Full Text] [Related]
14. Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model. Tollefson AE; Spencer JF; Ying B; Buller RM; Wold WS; Toth K Antiviral Res; 2014 Dec; 112():38-46. PubMed ID: 25453340 [TBL] [Abstract][Full Text] [Related]
15. HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model. Toth K; Spencer JF; Ying B; Tollefson AE; Wold WSM Viruses; 2017 Jun; 9(6):. PubMed ID: 28608847 [TBL] [Abstract][Full Text] [Related]
16. Oral Vaccination with Replication-Competent Adenovirus in Mice Reveals Dissemination of the Viral Vaccine beyond the Gastrointestinal Tract. Goffin E; Javaux J; Destexhe E; Pretto CD; Spindler KR; Machiels B; Gillet L J Virol; 2019 Jul; 93(13):. PubMed ID: 30996103 [TBL] [Abstract][Full Text] [Related]
18. New drug on the horizon for treating adenovirus. Wold WS; Toth K Expert Opin Pharmacother; 2015; 16(14):2095-9. PubMed ID: 26330121 [TBL] [Abstract][Full Text] [Related]
19. Mouse adenovirus type 1-induced breakdown of the blood-brain barrier. Gralinski LE; Ashley SL; Dixon SD; Spindler KR J Virol; 2009 Sep; 83(18):9398-410. PubMed ID: 19570856 [TBL] [Abstract][Full Text] [Related]
20. Oral USC-093, a novel homoserinamide analogue of the tyrosinamide (S)-HPMPA prodrug USC-087 has decreased nephrotoxicity while maintaining antiviral efficacy against human adenovirus infection of Syrian hamsters. Tollefson AE; Riemann SB; Ying B; Spencer JF; Overhulse JM; Kashemirov BA; Wold WSM; McKenna CE; Toth K Antiviral Res; 2024 Feb; 222():105799. PubMed ID: 38190973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]